Johnson & Johnson is at the forefront of healthcare innovation, leveraging artificial intelligence and robotics to enhance its product offerings. The company has recently launched AI-powered imaging and mapping capabilities specifically designed for electrophysiology.
In addition to its advancements in imaging, J&J is seeing early momentum with a new drug delivery system aimed at treating bladder cancer. This system promises to improve patient outcomes and streamline treatment processes.
Furthermore, the company is progressing towards developing a table-integrated robotic surgical system, which is expected to revolutionize surgical procedures by increasing precision and efficiency.